Bayesian Capital Management LP Buys Shares of 53,909 Aspen Aerogels, Inc. (NYSE:ASPN)

Bayesian Capital Management LP bought a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 53,909 shares of the construction company's stock, valued at approximately $640,000. Bayesian Capital Management LP owned approximately 0.07% of Aspen Aerogels as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Vanguard Group Inc. raised its holdings in Aspen Aerogels by 5.5% in the fourth quarter. Vanguard Group Inc. now owns 4,360,246 shares of the construction company's stock worth $51,800,000 after buying an additional 226,251 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in shares of Aspen Aerogels by 25.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,018,631 shares of the construction company's stock valued at $23,983,000 after purchasing an additional 409,862 shares during the last quarter. Telemark Asset Management LLC boosted its position in Aspen Aerogels by 26.8% in the fourth quarter. Telemark Asset Management LLC now owns 1,892,424 shares of the construction company's stock worth $22,482,000 after purchasing an additional 400,000 shares during the last quarter. Geode Capital Management LLC boosted its position in Aspen Aerogels by 5.6% in the fourth quarter. Geode Capital Management LLC now owns 1,464,163 shares of the construction company's stock worth $17,398,000 after purchasing an additional 78,195 shares during the last quarter. Finally, Alyeska Investment Group L.P. purchased a new position in Aspen Aerogels in the fourth quarter worth about $9,504,000. Institutional investors own 97.64% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. TD Cowen raised shares of Aspen Aerogels to a "strong-buy" rating in a report on Tuesday, March 11th. StockNews.com raised shares of Aspen Aerogels to a "sell" rating in a report on Wednesday, February 19th. Roth Mkm decreased their price objective on shares of Aspen Aerogels from $22.00 to $16.00 and set a "buy" rating on the stock in a research report on Friday, February 14th. Oppenheimer downgraded shares of Aspen Aerogels from an "outperform" rating to a "market perform" rating in a report on Thursday. Finally, Seaport Res Ptn downgraded shares of Aspen Aerogels from a "strong-buy" rating to a "hold" rating in a report on Wednesday, February 12th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Aspen Aerogels presently has an average rating of "Moderate Buy" and a consensus target price of $19.11.

Aspen Aerogels Price Performance

Shares of NYSE:ASPN traded up $0.40 during midday trading on Monday, reaching $5.35. 1,102,835 shares of the company were exchanged, compared to its average volume of 1,931,173. The company has a current ratio of 2.93, a quick ratio of 2.48 and a debt-to-equity ratio of 0.27. The business's fifty day moving average is $6.08 and its two-hundred day moving average is $10.46. Aspen Aerogels, Inc. has a one year low of $4.16 and a one year high of $33.15. The stock has a market cap of $438.85 million, a PE ratio of 33.20 and a beta of 2.72.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its earnings results on Thursday, May 8th. The construction company reported ($0.06) earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. The firm had revenue of $78.72 million during the quarter, compared to analyst estimates of $82.75 million. During the same quarter in the prior year, the business earned ($0.02) earnings per share. Aspen Aerogels's revenue for the quarter was down 16.7% on a year-over-year basis. As a group, analysts predict that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current year.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.